Skip to main content
. 2017 Aug 28;1(20):1645–1649. doi: 10.1182/bloodadvances.2017009613

Table 1.

Demographics and medications by treatment arm

Regadenoson, n = 53 Placebo, n = 47 P
Age, median (range), y 25 (10-54) 26 (13-56) .29
Pediatric, <18 y (%) 6 (11) 8 (17) .57
Sex (%) .42
 Female 22 (42) 24 (51)
 Male 31 (58) 23 (49)
Race (%) 1.0
 Black or African American 49 (92) 44 (94)
 Other 4 (8) 3 (6)
Currently taking hydroxyurea (%) 38 (72) 33 (70) 1.0